OB/GYN Clinical Alert (Vol. 33, No. 11) – March 1, 2017

Read the Disclosure Information Below, then click “Continue” to begin testing.

Release date: March 2017

Valid through: March 2020

Target Audience

This activity is intended for the obstetrician and gynecologist and nurses in OB/GYN practices.

Subjects

  • Zika, Revisited
  • Ovarian Cancer Screening: Mortality Results
  • Fertility of Boys Resulting from Intracytoplasmic Sperm Injection
  • Reproductive Rights in 2017: Standing Strong for Women

Objectives

  • Explain the latest data regarding diagnosis and treatment of various diseases affecting women
  • Discuss new data concerning prenatal care, neonatal health, and complications arising in pregnancy and the perinatal period
  • Discuss the advantages, disadvantages, and cost-effectiveness of new testing procedures in women

Credit Available

Physicians

  • Maximum of 2.25 AMA PRA Category 1 Credits

Nurses

  • Maximum of 2.25 nursing contact hours

Sponsor

This activity is sponsored by AHC Media.

Accreditation Statement

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Relias Learning, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Credit Designation

Physicians

AHC Media designates this enduring material for a maximum of 2.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

Relias Learning, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. This activity has been approved for 2.25 nursing contact hours using a 60-minute contact hour. Provider approved by the California Board of Registered Nursing, Provider #CEP13791, for 27 Contact Hours.

Faculty Listing

Authors

John C. Hobbins, MD, Professor, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora

Molly A. Brewer, DVM, MD, MS, Professor and Chair, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Connecticut Health Center, Farmington, CT

Robert W. Rebar, MD, Professor, Department of Obstetrics and Gynecology, Western Michigan Homer Stryker M.D. School of Medicine, Kalamazoo

Jeffrey T. Jensen, MD, MPH, Leon Speroff Professor and Vice Chair for Research, Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland

Editors

Medical Editor: Jeffrey T. Jensen, MD, MPH

Peer Reviewer: Catherine Leclair, MD

Nurse Planner: Marci Messerle Forbes, RN, FNP

Nurse Planner: Andrea O’Donnell, RN, FNP

AHC Media Executive Editor: Leslie G. Coplin

Assistant Editor: Jonathan Springston

Financial Disclosure

Jeffrey T. Jensen, MD, MPH reports he is a consultant for and receives grant/research support from Bayer, Abbvie, ContraMed, and Merck he receives grant research support from Medicines360, Agile and Teva, and is a consultant for MicroChips and Evofem. John C. Hobbins, MD, Molly A. Brewer, DVM, MD, MS, and Robert W. Rebar, MD report no financial relationships relevant to this field of study.

OB/GYN Clinical Alert's Editor, Jeffrey T. Jensen, MD, MPH, reports he is a consultant for and receives grant/research support from Bayer, Abbvie, ContraMed, and Merck he receives grant research support from Medicines360, Agile and Teva, and is a consultant for MicroChips and Evofem.

Peer Reviewer Catherine Leclair, MD, Nurse Planners Marci Messerle Forbes, RN, FNP, and Andrea O’Donnell, RN, FNP, AHC Media Editorial Group Manager Terrey L. Hatcher, Executive Editor Leslie G. Coplin, and Editor Jonathan Springston report no financial relationships relevant to this field of study.

Copyright 2017, AHC Media. All rights reserved.